Europe Ipilimumab Market Report 2016

November 2016 | 105 pages | ID: E914BB42CC2EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ipilimumab

Revenue, means the sales value of Ipilimumab

This report studies sales (consumption) of Ipilimumab in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Pfizer
• Novartis
• Bayer
• Roche
• Bristol-Myers Squibb
• Merck & Co.
• Exelixis

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Ipilimumab in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Ipilimumab in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Ipilimumab Market Report 2016

1 IPILIMUMAB OVERVIEW

1.1 Product Overview and Scope of Ipilimumab
1.2 Classification of Ipilimumab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Ipilimumab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Ipilimumab Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Ipilimumab (2011-2021)
  1.5.1 Europe Ipilimumab Sales and Growth Rate (2011-2021)
  1.5.2 Europe Ipilimumab Revenue and Growth Rate (2011-2021)

2 EUROPE IPILIMUMAB BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Ipilimumab Market Competition by Manufacturers
  2.1.1 Europe Ipilimumab Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Ipilimumab Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Ipilimumab (Volume and Value) by Type
  2.2.1 Europe Ipilimumab Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Ipilimumab Revenue and Market Share by Type (2011-2016)
2.3 Europe Ipilimumab (Volume and Value) by Countries
  2.3.1 Europe Ipilimumab Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Ipilimumab Revenue and Market Share by Countries (2011-2016)
2.4 Europe Ipilimumab (Volume) by Application

3 GERMANY IPILIMUMAB (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Ipilimumab Sales and Value (2011-2016)
  3.1.1 Germany Ipilimumab Sales and Growth Rate (2011-2016)
  3.1.2 Germany Ipilimumab Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Ipilimumab Sales Price Trend (2011-2016)
3.2 Germany Ipilimumab Sales and Market Share by Manufacturers
3.3 Germany Ipilimumab Sales and Market Share by Type
3.4 Germany Ipilimumab Sales and Market Share by Application

4 FRANCE IPILIMUMAB (VOLUME, VALUE AND SALES PRICE)

4.1 France Ipilimumab Sales and Value (2011-2016)
  4.1.1 France Ipilimumab Sales and Growth Rate (2011-2016)
  4.1.2 France Ipilimumab Revenue and Growth Rate (2011-2016)
  4.1.4 France Ipilimumab Sales Price Trend (2011-2016)
4.2 France Ipilimumab Sales and Market Share by Manufacturers
4.3 France Ipilimumab Sales and Market Share by Type
4.4 France Ipilimumab Sales and Market Share by Application

5 UK IPILIMUMAB (VOLUME, VALUE AND SALES PRICE)

5.1 UK Ipilimumab Sales and Value (2011-2016)
  5.1.1 UK Ipilimumab Sales and Growth Rate (2011-2016)
  5.1.2 UK Ipilimumab Revenue and Growth Rate (2011-2016)
  5.1.5 UK Ipilimumab Sales Price Trend (2011-2016)
5.2 UK Ipilimumab Sales and Market Share by Manufacturers
5.3 UK Ipilimumab Sales and Market Share by Type
5.4 UK Ipilimumab Sales and Market Share by Application

6 RUSSIA IPILIMUMAB (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Ipilimumab Sales and Value (2011-2016)
  6.1.1 Russia Ipilimumab Sales and Growth Rate (2011-2016)
  6.1.2 Russia Ipilimumab Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Ipilimumab Sales Price Trend (2011-2016)
6.2 Russia Ipilimumab Sales and Market Share by Manufacturers
6.3 Russia Ipilimumab Sales and Market Share by Type
6.4 Russia Ipilimumab Sales and Market Share by Application

7 ITALY IPILIMUMAB (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Ipilimumab Sales and Value (2011-2016)
  7.1.1 Italy Ipilimumab Sales and Growth Rate (2011-2016)
  7.1.2 Italy Ipilimumab Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Ipilimumab Sales Price Trend (2011-2016)
7.2 Italy Ipilimumab Sales and Market Share by Manufacturers
7.3 Italy Ipilimumab Sales and Market Share by Type
7.4 Italy Ipilimumab Sales and Market Share by Application

8 SPAIN IPILIMUMAB (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Ipilimumab Sales and Value (2011-2016)
  8.1.1 Spain Ipilimumab Sales and Growth Rate (2011-2016)
  8.1.2 Spain Ipilimumab Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Ipilimumab Sales Price Trend (2011-2016)
8.2 Spain Ipilimumab Sales and Market Share by Manufacturers
8.3 Spain Ipilimumab Sales and Market Share by Type
8.4 Spain Ipilimumab Sales and Market Share by Application

9 BENELUX IPILIMUMAB (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Ipilimumab Sales and Value (2011-2016)
  9.1.1 Benelux Ipilimumab Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Ipilimumab Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Ipilimumab Sales Price Trend (2011-2016)
9.2 Benelux Ipilimumab Sales and Market Share by Manufacturers
9.3 Benelux Ipilimumab Sales and Market Share by Type
9.4 Benelux Ipilimumab Sales and Market Share by Application

10 EUROPE IPILIMUMAB MANUFACTURERS ANALYSIS

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Ipilimumab Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Pfizer Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Novartis
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Ipilimumab Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Novartis Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Bayer
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Ipilimumab Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Bayer Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Roche
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Ipilimumab Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Roche Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Bristol-Myers Squibb
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Ipilimumab Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Bristol-Myers Squibb Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Merck & Co.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Ipilimumab Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Merck & Co. Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Exelixis
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Ipilimumab Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Exelixis Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview

11 IPILIMUMAB MANUFACTURING COST ANALYSIS

11.1 Ipilimumab Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Ipilimumab

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Ipilimumab Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Ipilimumab Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE IPILIMUMAB MARKET FORECAST (2016-2021)

14.1 Germany Ipilimumab Sales Forecast (2016-2021)
14.2 France Ipilimumab Sales Forecast (2016-2021)
14.3 UK Ipilimumab Sales Forecast (2016-2021)
14.4 Russia Ipilimumab Sales Forecast (2016-2021)
14.5 Italy Ipilimumab Sales Forecast (2016-2021)
14.6 Spain Ipilimumab Sales Forecast (2016-2021)
14.7 Benelux Ipilimumab Sales Forecast (2016-2021)
14.8 Europe Ipilimumab Sales Forecast by Type (2016-2021)
14.9 Europe Ipilimumab Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ipilimumab
Table Classification of Ipilimumab
Figure Europe Sales Market Share of Ipilimumab by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Ipilimumab
Figure Europe Sales Market Share of Ipilimumab by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Ipilimumab Revenue and Growth Rate (2011-2021)
Figure France Ipilimumab Revenue and Growth Rate (2011-2021)
Figure UK Ipilimumab Revenue and Growth Rate (2011-2021)
Figure Russia Ipilimumab Revenue and Growth Rate (2011-2021)
Figure Italy Ipilimumab Revenue and Growth Rate (2011-2021)
Figure Spain Ipilimumab Revenue and Growth Rate (2011-2021)
Figure Benelux Ipilimumab Revenue and Growth Rate (2011-2021)
Figure Europe Ipilimumab Sales and Growth Rate (2011-2021)
Figure Europe Ipilimumab Revenue and Growth Rate (2011-2021)
Table Europe Ipilimumab Sales of Key Manufacturers (2015 and 2016)
Table Europe Ipilimumab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ipilimumab Sales Share by Manufacturers
Figure 2016 Ipilimumab Sales Share by Manufacturers
Table Europe Ipilimumab Revenue by Manufacturers (2015 and 2016)
Table Europe Ipilimumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Ipilimumab Revenue Share by Manufacturers
Table 2016 Europe Ipilimumab Revenue Share by Manufacturers
Table Europe Ipilimumab Sales and Market Share by Type (2011-2016)
Table Europe Ipilimumab Sales Share by Type (2011-2016)
Figure Sales Market Share of Ipilimumab by Type (2011-2016)
Figure Europe Ipilimumab Sales Growth Rate by Type (2011-2016)
Table Europe Ipilimumab Revenue and Market Share by Type (2011-2016)
Table Europe Ipilimumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ipilimumab by Type (2011-2016)
Figure Europe Ipilimumab Revenue Growth Rate by Type (2011-2016)
Table Europe Ipilimumab Sales and Market Share by Countries (2011-2016)
Table Europe Ipilimumab Sales Share by Countries (2011-2016)
Figure Sales Market Share of Ipilimumab by Countries (2011-2016)
Table Europe Ipilimumab Revenue and Market Share by Countries (2011-2016)
Table Europe Ipilimumab Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Ipilimumab by Countries (2011-2016)
Table Europe Ipilimumab Sales and Market Share by Application (2011-2016)
Table Europe Ipilimumab Sales Share by Application (2011-2016)
Figure Sales Market Share of Ipilimumab by Application (2011-2016)
Figure Germany Ipilimumab Sales and Growth Rate (2011-2016)
Figure Germany Ipilimumab Revenue and Growth Rate (2011-2016)
Figure Germany Ipilimumab Sales Price Trend (2011-2016)
Table Germany Ipilimumab Sales by Manufacturers (2015 and 2016)
Table Germany Ipilimumab Market Share by Manufacturers (2015 and 2016)
Table Germany Ipilimumab Sales by Type (2015 and 2016)
Table Germany Ipilimumab Market Share by Type (2015 and 2016)
Table Germany Ipilimumab Sales by Application (2015 and 2016)
Table Germany Ipilimumab Market Share by Application (2015 and 2016)
Figure France Ipilimumab Sales and Growth Rate (2011-2016)
Figure France Ipilimumab Revenue and Growth Rate (2011-2016)
Figure France Ipilimumab Sales Price Trend (2011-2016)
Table France Ipilimumab Sales by Manufacturers (2015 and 2016)
Table France Ipilimumab Market Share by Manufacturers (2015 and 2016)
Table France Ipilimumab Sales by Type (2015 and 2016)
Table France Ipilimumab Market Share by Type (2015 and 2016)
Table France Ipilimumab Sales by Application (2015 and 2016)
Table France Ipilimumab Market Share by Application (2015 and 2016)
Figure UK Ipilimumab Sales and Growth Rate (2011-2016)
Figure UK Ipilimumab Revenue and Growth Rate (2011-2016)
Figure UK Ipilimumab Sales Price Trend (2011-2016)
Table UK Ipilimumab Sales by Manufacturers (2015 and 2016)
Table UK Ipilimumab Market Share by Manufacturers (2015 and 2016)
Table UK Ipilimumab Sales by Type (2015 and 2016)
Table UK Ipilimumab Market Share by Type (2015 and 2016)
Table UK Ipilimumab Sales by Application (2015 and 2016)
Table UK Ipilimumab Market Share by Application (2015 and 2016)
Figure Russia Ipilimumab Sales and Growth Rate (2011-2016)
Figure Russia Ipilimumab Revenue and Growth Rate (2011-2016)
Figure Russia Ipilimumab Sales Price Trend (2011-2016)
Table Russia Ipilimumab Sales by Manufacturers (2015 and 2016)
Table Russia Ipilimumab Market Share by Manufacturers (2015 and 2016)
Table Russia Ipilimumab Sales by Type (2015 and 2016)
Table Russia Ipilimumab Market Share by Type (2015 and 2016)
Table Russia Ipilimumab Sales by Application (2015 and 2016)
Table Russia Ipilimumab Market Share by Application (2015 and 2016)
Figure Italy Ipilimumab Sales and Growth Rate (2011-2016)
Figure Italy Ipilimumab Revenue and Growth Rate (2011-2016)
Figure Italy Ipilimumab Sales Price Trend (2011-2016)
Table Italy Ipilimumab Sales by Manufacturers (2015 and 2016)
Table Italy Ipilimumab Market Share by Manufacturers (2015 and 2016)
Table Italy Ipilimumab Sales by Type (2015 and 2016)
Table Italy Ipilimumab Market Share by Type (2015 and 2016)
Table Italy Ipilimumab Sales by Application (2015 and 2016)
Table Italy Ipilimumab Market Share by Application (2015 and 2016)
Figure Spain Ipilimumab Sales and Growth Rate (2011-2016)
Figure Spain Ipilimumab Revenue and Growth Rate (2011-2016)
Figure Spain Ipilimumab Sales Price Trend (2011-2016)
Table Spain Ipilimumab Sales by Manufacturers (2015 and 2016)
Table Spain Ipilimumab Market Share by Manufacturers (2015 and 2016)
Table Spain Ipilimumab Sales by Type (2015 and 2016)
Table Spain Ipilimumab Market Share by Type (2015 and 2016)
Table Spain Ipilimumab Sales by Application (2015 and 2016)
Table Spain Ipilimumab Market Share by Application (2015 and 2016)
Figure Benelux Ipilimumab Sales and Growth Rate (2011-2016)
Figure Benelux Ipilimumab Revenue and Growth Rate (2011-2016)
Figure Benelux Ipilimumab Sales Price Trend (2011-2016)
Table Benelux Ipilimumab Sales by Manufacturers (2015 and 2016)
Table Benelux Ipilimumab Market Share by Manufacturers (2015 and 2016)
Table Benelux Ipilimumab Sales by Type (2015 and 2016)
Table Benelux Ipilimumab Market Share by Type (2015 and 2016)
Table Benelux Ipilimumab Sales by Application (2015 and 2016)
Table Benelux Ipilimumab Market Share by Application (2015 and 2016)
Table Ipilimumab Basic Information List
Table Pfizer Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Ipilimumab Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Ipilimumab Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Ipilimumab Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Ipilimumab Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Ipilimumab Sales Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Ipilimumab Sales Market Share (2011-2016)
Table Exelixis Basic Information List
Table Exelixis Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Exelixis Ipilimumab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ipilimumab
Figure Manufacturing Process Analysis of Ipilimumab
Figure Ipilimumab Industrial Chain Analysis
Table Raw Materials Sources of Ipilimumab Major Manufacturers in 2015
Table Major Buyers of Ipilimumab
Table Distributors/Traders List
Figure Germany Ipilimumab Sales and Growth Rate Forecast (2016-2021)
Figure Germany Ipilimumab Revenue and Growth Rate Forecast (2016-2021)
Figure France Ipilimumab Sales and Growth Rate Forecast (2016-2021)
Figure France Ipilimumab Revenue and Growth Rate Forecast (2016-2021)
Figure UK Ipilimumab Sales and Growth Rate Forecast (2016-2021)
Figure UK Ipilimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Ipilimumab Sales and Growth Rate Forecast (2016-2021)
Figure Russia Ipilimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Ipilimumab Sales and Growth Rate Forecast (2016-2021)
Figure Italy Ipilimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Ipilimumab Sales and Growth Rate Forecast (2016-2021)
Figure Spain Ipilimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Ipilimumab Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Ipilimumab Revenue and Growth Rate Forecast (2016-2021)
Table Europe Ipilimumab Sales Forecast by Type (2016-2021)
Table Europe Ipilimumab Sales Forecast by Application (2016-2021 )